Mean dose to the tongue mucosa did not improve predictions of taste impairment during and after radiation therapy compared ...

"We are proud to contribute to research in head and neck and other forms of cancer to learn more about causes and treatments.

Designation applies to the treatment of adult patients with recurrent or metastatic head and neck squamous cell carcinoma ...

Ficerafusp alfa enters phase 2/3 trial for recurrent/metastatic head and neck cancer, evaluating its combination with ...

These useful findings assigned a novel functional implication of histone acylation, crotonylation. Although the mechanistic insights have been provided in great detail regarding the role of the YEATS2 ...

The FDA accepted for priority review a supplemental Biologics License Application for Keytruda for resectable locally ...

Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.

Professor and surgeon Jason Hunt, MD, MS, FACS, has been named inaugural Chair of the Department of Otolaryngology – Head and ...

HPV causes irritating warts, or lesions, on the back, front, or side of the tongue. Males have a higher risk of developing ...

A physician-scientist at the University of Oklahoma is part of an international effort seeking new options for patients with head and neck cancer who cannot receive the standard chemotherapy drug ...

The study will target a specific patient group: those with newly diagnosed resectable stage 3 and 4 head and neck cancer, no lymph node involvement, and low PD-L1 tumor expression. The previous ...

Inpatient immune checkpoint inhibitor treatment produces poor outcomes across cancer types, according to the largest study of its kind.